| George M Pikler, MD | |
|
2220 Canterbury Dr, Hays, KS 67601-2370 | |
| (785) 623-5774 | |
| Not Available |
| Full Name | George M Pikler |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 2220 Canterbury Dr, Hays, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902974603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 22260 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| George M Pikler, MD 1121 E 19th St, Tulsa, OK 74120-7416 Ph: (918) 582-2019 | George M Pikler, MD 2220 Canterbury Dr, Hays, KS 67601-2370 Ph: (785) 623-5774 |
News Archive
Women undergoing treatment for breast cancer are widely prescribed calcium and vitamin D supplements to prevent and manage osteoporosis, an unwanted side effect of breast cancer therapies.
With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized.
Oxford Nanopore has launched new '109' cDNA Kits for its real-time, scalable sequencing technology. The new kits provide high throughput whilst generating complete sequences of full-length cDNA strands, with a low input option of just 1ng PolyA+ RNA.
With the threat of a shortage of protective masks looming as the novel coronavirus pandemic grows, Medical University of South Carolina biomedical engineers and tinkerers had an inspired idea: unleash an army of makers from across the U.S. who could make such masks from 3D printers - a technology that, in recent years, has become widely available.
Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $750,000,000 in aggregate principal amount in two series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions.
› Verified 4 days ago
Dr. Seema Kirit Patel, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr, Suite 202, Hays, KS 67601 Phone: 785-623-2312 Fax: 785-623-2323 | |
Edgardo Olvera Lopez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5591 | |
Dr. Jeffery Lane Curtis, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 600 Park Street, Css-301, Hays, KS 67601 Phone: 785-628-4401 Fax: 785-628-4089 | |
John Kimbugwe, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5591 Fax: 785-623-5045 | |
Hema Pamulapati, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-625-4699 | |
Dr. Dana Allen Young, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2214 Canterbury Dr Ste 202, Hays, KS 67601 Phone: 785-623-2312 Fax: 785-623-2323 | |
Dr. Steven D Rankin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5591 Fax: 785-623-5524 |